Quick Reference

POTS Clinical Quick Reference

Print-ready summary card. Use Ctrl+P / Cmd+P to print or save as PDF.

POTS — Physician Quick Reference Card

Dr Boon Lim · Imperial College Healthcare NHS Trust · stopfainting.com

StopFainting.com

POTS UK Educational Partner

Definition

Postural Tachycardia Syndrome — abnormality of the autonomic nervous system causing excessive HR rise on standing, with orthostatic symptoms.

  • • Affects ~1% of the UK population
  • • 80–85% female, onset age 15–50
  • • Average diagnostic delay: 7 years
  • • >50% initially misdiagnosed as anxiety

Diagnostic Criteria (all required)

  1. 1HR rise ≥30 bpm (adults) / ≥40 bpm (12–19 yrs) within 10 min of standing
  2. 2No orthostatic hypotension (SBP drop <20, DBP drop <10 mmHg)
  3. 3Orthostatic symptoms present (palpitations, dizziness, presyncope)
  4. 4Symptoms for ≥3 months
⚠ If resting HR <60 bpm, use 60 as baseline. Thresholds need not be met at every visit.

Active Stand Test Protocol

Prep

Supine ≥10 min. No caffeine/vasoactive meds. Record baseline HR + BP.

Stand

Patient stands unaided. Record HR at 1 min; BP at 1 min.

3 min

Record HR + BP at 3 minutes standing.

5 min

Record HR + BP at 5 minutes standing.

10 min

Record HR + BP. Calculate MALMO Score. Stop if presyncope.

Result

HR rise ≥30 bpm sustained ≥10 min + symptoms + no OH = POTS.

Key Symptoms

Palpitations on standing
Brain fog
Dizziness / presyncope
Orthostatic headaches (~30%)
Syncope (30–60%)
Sleep disturbance
Chest pain (upright)
Gut problems
Shortness of breath
'PoTS feet' (purple, ~50%)
Exercise intolerance
Fatigue / PEM

Stepwise Management

1st
  • • Explain & reassure
  • • Salt 8–10g/day + fluids 2–3L/day
  • • Head-of-bed elevation 10–15cm
  • • Compression garments (30–40 mmHg)
2nd
  • • Counter-manoeuvres (leg cross, squat, toe raise)
  • • Structured exercise — Levine Protocol
  • • Small frequent meals, avoid alcohol
3rd
  • • Fludrocortisone 0.05–0.2mg (hypovolaemic)
  • • Propranolol 10–40mg TDS (hyperadrenergic)
  • • Ivabradine 2.5–7.5mg BD (HR-dominant)
  • • Midodrine 2.5–10mg TDS (neuropathic)

When to Refer

  • Refractory after 3–6 months optimised treatment
  • Suspected hyperadrenergic POTS
  • Complex comorbidities (hEDS, MCAS, autoimmune)
  • Post-COVID POTS with severe impairment
  • Diagnostic uncertainty after active stand test

Key Resources

  • 🌐 stopfainting.com — Dr Boon Lim
  • 🌐 potsuk.org — Patient charity (No. 1159813)
  • 📱 POTS UK 13-module education programme (co-created with Dr Boon Lim)
  • 🔗 Interactive Active Stand Test Calculator: stopfainting.com/tools/active-stand-test

© 2026 Dr Boon Lim · Imperial College Healthcare NHS Trust · For clinical education only. Not a substitute for individual patient assessment.

v1.0 · stopfainting.com